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Abstract. This paper presents the design and development of the
CloudUPDRS app and supporting system developed as a Class I medical
device to assess the severity of motor symptoms for Parkinson’s Disease.
We report on lessons learnt towards meeting fidelity and regulatory re-
quirements; effective procedures employed to structure user context and
ensure data quality; a robust service provision architecture; a depend-
able analytics toolkit; and provisions to meet mobility and social needs
of people with Parkinson’s.
1 Introduction
It is well understood that modern smartphones present unique opportunities for
mobile healthcare. Indeed, there are numerous wellness and self-tracking apps
readily available in all major mobile phone platform markets and many more
have been developed to conduct research in various aspects of mobile telecare.
Yet, the vast majority of these apps do not conform to the safety, quality, perfor-
mance and regulatory requirements set for medical devices and as such they can
only be employed either to encourage a healthy lifestyle or for research purposes
correspondingly, but are not tools for medical diagnosis. This fact is often ex-
plicitly reflected in their terms and conditions of use for example, quoting from
a popular Parkinson’s Disease app, the developers state that “we cannot, and
thus we do not, guarantee or promise that you will personally receive any direct
benefits.” In contrast to this situation, this paper presents the design and de-
velopment of the CloudUPDRS app and its associated information management
and analytics platform, which meets the standards set for medical devices. In
particular, we describe how CloudUPDRS achieves the accurate, precise, and
repeatable assessment of motor symptoms for people with Parkinson’s (PwP),
which clinicians can use with confidence. The app is currently undergoing exam-
ination by the Medicines and Healthcare products Regulatory Agency (MHRA)
in the UK towards its full registration as a medical device.
The successful development and operational deployment of the CloudUP-
DRS app and its supporting service at the level required to achieve conformal
performance to medical device regulations, thus establishing it as a valuable di-
agnostic tool for clinicians, demanded that we address several key problems. In
2 Authors Suppressed Due to Excessive Length
Fig. 1. Views of the user interface of the CloudUPDRS app showing session manage-
ment, tremor recording and finger tapping activities..
this paper we present the key contributions of this work towards achieving this
goal. Specifically, we describe:
– How to effectively combine a guided data collection procedure imposed by the
app to provide structured user context, with a fully automated signal process-
ing pipeline thus making possible the unsupervised but consistent interpre-
tation of sensor data captured during the performance of motor assessment
activities.
– The development of a data analytics toolkit for the assessment of tremor,
bradykenesia and gait measurements following the MDS Unified Parkinson’s
Disease Rating Scale, the standard clinical tool for the diagnosis of PD.
– The development of an information management, data mining and dashboard
service developed following the concept of microservices and the lambda archi-
tecture, incorporating stream and batch processing pathways to ensure scale
out performance and responsiveness.
2 Background and Rationale
PD symptoms are typically caused by the loss of neurones that produce dopamine,
a key chemical messenger in the brain, decreased levels of which lead to abnor-
mal brain activity (cf. [1] for more details). Care for patients with PD involves
the management of both motor and non-motor symptoms as well as palliative
care.
Since symptoms vary greatly independent of treatment and PD progresses at
different rates in different individuals, it requires regular clinical monitoring and
medication adjustment. Monitoring and adjustment however require hospital
visits and assessment under the standard Movement Disorders Society’s Unified
Parkinson’s Disease Rating Scale (mds-updrs) [2]. Due to these constraints,
such reviews are relatively infrequent, carried out typically only a few times per
year. This in turn limits opportunities to precisely quantify PD progression and
the effectiveness of patient stratification [8]: the restricted availability of data
concerning individual variability and actual symptom trends limit opportunities
to adapt care to the needs of a particular individual at a specific time.
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Indeed, it is possible to employ certain aspects of movement that are dis-
rupted in Parkinson’s as surrogate biomarkers of dopamine levels and in fact
this is precisely the purpose of Part III of the mds-updrs. Further pursuing this
insight, in [3] we investigated the possibility to precisely quantify and implement
the mds-updrs methodology as a smartphone app to enable the assessment of
motor performance through tremor, gait and bradykinesia measurements ob-
tained from standard sensors embedded in smartphones within a clinical set-
ting. By adopting this approach, we also intend to capture in-depth medical
intelligence supporting the discovery of longitudinal trends, promoting deeper
understanding of the patterns of normal daily symptom variations, and predict-
ing the onset of dyskinesias thus facilitating high-precision personalised targeting
of treatment.
3 The CloudUPDRS app
As discussed in the previous Section, in [3] we demonstrate the feasibility of
using smartphones as a means to assess commonly occurring motor symptoms
of PD in a clinical setting. Specifically, we designed, developed and validated in a
field study a prototype app on Android implementing Part III of the mds-updrs.
Using the accelerometer and touch screen sensors commonly available in modern
smartphones, we are able to carry out hand and leg tremor measurements, as
well as gait and bradykinesia assessments using finger tapping tasks to replicate
the majority of these tests. In [3] tests were administered by an experienced
clinician in the lab using an HTC Desire device and the collected sensor data
were extracted and processed using standard biomedical data analysis software.
Participants were also tested in the same areas of motor performance using the
standard lab procedure outlined in mds-updrs and using bespoke biomedical
data acquisition equipment to obtain a baseline for comparing the performance
of the app.
In CloudUPDRS we employ the data collection and analysis techniques de-
scribed in [3] to develop an app with extended functionality that enables its
independent but dependable use by PwP and their carers at home and in their
communities. The app implements a comprehensive workflow partially depicted
in Figure 1, which provides audio, video and textual guidance on how to con-
duct the actions required by the tests and automatically adapts to match the
specifications of its host device. The app is also provisioned with a delay toler-
ant background service to manage session data that ensures that information is
safely submitted for further processing to a supporting online service also devel-
oped specifically to provide this function and described in more detail in Section
4 below.
Overall, the CloudUPDRS system consists of the following elements:
1. PD patient smartphone apps for Android and iOS that carry out motor per-
formance measurements and wellness self-assessment; conduct session man-
agement; securely transfer captured data to the CloudUPDRS service; and,
present an interface providing guidance and feedback.
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2. Cloud-based scalable dat collection engine that safely and securely collects
data from patients’ smartphones; ensures secure data management; and ap-
plies the mds-updrs processing pipeline.
3. Data-mining toolkit for medical intelligence incorporating quantitative and
semi-structured data, and longitudinal analyses, clustering and classification;
and a clinical user interface incorporating visualisation.
4 The CloudUPDRS Service Platform
The CloudUPDRS service platform enables the secure capture, management and
analysis of data collected by the app and provides effective communication of
insights generated to clinicians enabling them to explore alternative treatment
scenarios. To cater for the diverse needs of the PwP population in the UK,
the platform has been engineered to facilitate scalable performance by adopting
the microservices architecture [9]. The microservices architectural style is set
in contrast to traditional monolithic web applications and aims to maximise
opportunities for vertical decomposition and scaling-out, which are critical for
high performance and service resilience in data intensive situations.
In CloudUPDRS, microservices are loosely coupled and employ lightweight
communication and coordination mechanisms such as the Consumer-Driven Con-
tract pattern and implemented on Apache Thrift (cf. https://thrift.apache.
org/) selected due to its highly efficient and compact protocol structure. System
componentization follows the design displayed in Figure 2, enforced via version-
ing of published RESTful interfaces. CloudUPDRS microservices are deployed
as docker containers (cf. https://www.docker.com/) although internal imple-
mentation details vary to match the specific preferences and expertise of project
partners responsible for their implementation and their suitability for the task in
hand. For example, while the data collection and signal processing APIs are im-
plemented using python and django REST within an nginx/gunicorn container,
semi-structured longitudinal analytics are implemented as Ruby bundles.
Finally, the service platform has been designed with the expectation that
in order to meet performance metrics for its interactive features at full opera-
tion scale it will require the on the fly integration of archived information from
its longitudinal datastore with real-time streams captured for example during
concurrent patient consultations. To facilitate this modus operandi, we have
structured workflows implemented through microservices following the lambda
architecture [7], which provides an intuitive model for the fusion of both types
of data on the fly.
5 Lessons Learnt and Conclusions
Bounded Context. The pervasive computing community has invested significant
effort in techniques for modelling and adapting to user context, which is crit-
ical for the interpretation of sensor data streams. This role for context was
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Fig. 2. CloudUPDRS microservices implementing the lambda architecture.
re-confirmed in our work and in the case of the Intel/Fox Foundation project dis-
cussed above. Yet, when context modelling is not possible or incurs prohibitively
high costs, an effective alternative is to bound context by imposing structure and
thus predictability to user actions during sensing, an approach that was success-
fully applied with the CloudUPDRS app. Guided user experiences can contain
the degrees of freedom possible and as a consequence the computation of motor
performance indicators becomes consistent and repeatable.
Choice of Analytics. Recent years have also witnessed the rapid growth of
machine learning methods for sensed data as an active area of research. While
there are clearly situations when the development of new algorithms and tech-
niques is required, in other cases there seems to be good reason to opt for a
more traditional approach. In CloudUPDRS we discovered that in full-scale op-
erational systems predictability and consistency of algorithmic performance ob-
tained through extensive experience with the tradeoffs related in tuning machine
learning techniques, may be more valuable than higher but vacillating perfor-
mance.
Data Quality. Data quality in pervasive computing has often been investi-
gated by considering specific stages of the processing pipeline in isolation. In
CloudUPDRS rather than optimise individual stages we engineer an end-to-end
quality assurance strategy that we find to be more effective. It incorporates fea-
tures of the user experience, which permit the user to initiate the repeat of tests
when an external event has disrupted the session, to increasing the duration of
individual tests so as to enable oversampling and cross-validation, to employing
heuristics that allow us to quickly identify data quality problems in the captured
signal. We find that it is the combination of these features rather than any single
one alone that helps ensure a higher quality of data.
Certification. The higher standard of evidence demanded for the registration
of an app as a conforming medical device has significant resource implications.
Indeed, it is not surprising for development costs to be an order of magnitude
higher than those of an equivalent research project. The need for formal quality
assurance processes in particular adds considerable overheads. Consequently, it
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appears judicious to recognise commercial considerations from the earliest stages
of the process.
Microservices architecture. Although our experience in this area is incom-
plete, claims in favour of architectures build around microservices appear justi-
fied, especially for sensor data streaming mobile systems with execution profiles
similar to CloudUPDRS. Adoption of this approach has allowed greater flexibil-
ity during development, facilitated easy scaling-out of the service, and enabled
the development team to gain operational experience and hence effectively evolve
system features and performance.
In this paper we presented the design and development of the CloudUPDRS
app which has achieved Class I medical device conformity and we presented key
findings and techniques that helped us achieve this goal.
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